Back to Search
Start Over
Figure S1 from Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure S1. Flow diagram of patients included in the PK analysis, exposure-response analysis, and PD analysis datasets
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....5e0ed95c1b917b2a5631bb3bb1cd7cf9
- Full Text :
- https://doi.org/10.1158/1078-0432.22490332.v1